Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia

Michael Waddell, Samuel J. Flanders, Adam Golas, Quanwu Zhang, Rattan Juneja

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: While studies have evaluated the impact of hyperglycemia during hospitalization, little is known about its management before and after admission. Methods: We sampled a managed care outpatient database (8547 patients) with linkage to inpatient data from June 1, 2003 to June 30, 2006, evaluating hyperglycemia management preadmission (PA), during index admission (IA), and postdischarge (PD). Antihyperglycemic medications used during PA, IA, and PD for up to 15 months were available for 2898 patients from this cohort. Diabetes mellitus (DM) status was determined from ICD-9 codes. Results: Patients at IA had an average age of 60 ± 18 years. Forty-one percent were men and 59% were women. Nearly 60% of patients either had DM or manifested hyperglycemia (blood glucose > 130 mg/dL): 19.5% (1627) had preexisting DM (DM+); 9.6% (801) were newly diagnosed with DM at IA: 28.6% (2391) did not have DM (DM-) but manifested hyperglycemia during hospitalization; and 36.9% (3083) remained normoglycemic. The DM status of 459 patients (5.4%) was unascertainable. For the previously diagnosed DM+ patients, antidiabetic therapy intensified more than 2-fold during IA, primarily with insulin. Postdischarge hyperglycemia management medication doubled, with increases seen in both oral hypoglycemic agents (OHAs) and insulin. Newly diagnosed DM+ patients were also treated primarily with insulin during hospitalization and reverted to OHAs PD. A minority of DM-patients received antidiabetic therapy during IA, primarily with insulin, but 4% were diagnosed DM+ in the 15-month period PD and treated primarily with OHAs. Among those normoglycemic in the hospital, 1% were diagnosed with DM and treated with OHAs PD. Conclusion: Hyperglycemia management was intensified for all DM+ patients, primarily with insulin in the hospital and both insulin and OHAs PD. A better understanding of this natural history and antidiabetic transitional care could facilitate better discharge planning and thus improve diabetes care.

Original languageEnglish
Pages (from-to)61-66
Number of pages6
JournalPostgraduate Medicine
Volume121
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Patient Discharge
Hypoglycemic Agents
Hyperglycemia
Diabetes Mellitus
Insulin
Therapeutics
Hospitalization
International Classification of Diseases
Managed Care Programs
Natural History
Blood Glucose
Inpatients
Outpatients

Keywords

  • Diabetes
  • Hospital management
  • Hyperglycemia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia. / Waddell, Michael; Flanders, Samuel J.; Golas, Adam; Zhang, Quanwu; Juneja, Rattan.

In: Postgraduate Medicine, Vol. 121, No. 3, 05.2009, p. 61-66.

Research output: Contribution to journalArticle

Waddell, Michael ; Flanders, Samuel J. ; Golas, Adam ; Zhang, Quanwu ; Juneja, Rattan. / Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia. In: Postgraduate Medicine. 2009 ; Vol. 121, No. 3. pp. 61-66.
@article{dda7708e66604d73a150b8d889e9aac5,
title = "Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia",
abstract = "Background: While studies have evaluated the impact of hyperglycemia during hospitalization, little is known about its management before and after admission. Methods: We sampled a managed care outpatient database (8547 patients) with linkage to inpatient data from June 1, 2003 to June 30, 2006, evaluating hyperglycemia management preadmission (PA), during index admission (IA), and postdischarge (PD). Antihyperglycemic medications used during PA, IA, and PD for up to 15 months were available for 2898 patients from this cohort. Diabetes mellitus (DM) status was determined from ICD-9 codes. Results: Patients at IA had an average age of 60 ± 18 years. Forty-one percent were men and 59{\%} were women. Nearly 60{\%} of patients either had DM or manifested hyperglycemia (blood glucose > 130 mg/dL): 19.5{\%} (1627) had preexisting DM (DM+); 9.6{\%} (801) were newly diagnosed with DM at IA: 28.6{\%} (2391) did not have DM (DM-) but manifested hyperglycemia during hospitalization; and 36.9{\%} (3083) remained normoglycemic. The DM status of 459 patients (5.4{\%}) was unascertainable. For the previously diagnosed DM+ patients, antidiabetic therapy intensified more than 2-fold during IA, primarily with insulin. Postdischarge hyperglycemia management medication doubled, with increases seen in both oral hypoglycemic agents (OHAs) and insulin. Newly diagnosed DM+ patients were also treated primarily with insulin during hospitalization and reverted to OHAs PD. A minority of DM-patients received antidiabetic therapy during IA, primarily with insulin, but 4{\%} were diagnosed DM+ in the 15-month period PD and treated primarily with OHAs. Among those normoglycemic in the hospital, 1{\%} were diagnosed with DM and treated with OHAs PD. Conclusion: Hyperglycemia management was intensified for all DM+ patients, primarily with insulin in the hospital and both insulin and OHAs PD. A better understanding of this natural history and antidiabetic transitional care could facilitate better discharge planning and thus improve diabetes care.",
keywords = "Diabetes, Hospital management, Hyperglycemia",
author = "Michael Waddell and Flanders, {Samuel J.} and Adam Golas and Quanwu Zhang and Rattan Juneja",
year = "2009",
month = "5",
doi = "10.3810/pgm.2009.05.2003",
language = "English",
volume = "121",
pages = "61--66",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "3",

}

TY - JOUR

T1 - Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia

AU - Waddell, Michael

AU - Flanders, Samuel J.

AU - Golas, Adam

AU - Zhang, Quanwu

AU - Juneja, Rattan

PY - 2009/5

Y1 - 2009/5

N2 - Background: While studies have evaluated the impact of hyperglycemia during hospitalization, little is known about its management before and after admission. Methods: We sampled a managed care outpatient database (8547 patients) with linkage to inpatient data from June 1, 2003 to June 30, 2006, evaluating hyperglycemia management preadmission (PA), during index admission (IA), and postdischarge (PD). Antihyperglycemic medications used during PA, IA, and PD for up to 15 months were available for 2898 patients from this cohort. Diabetes mellitus (DM) status was determined from ICD-9 codes. Results: Patients at IA had an average age of 60 ± 18 years. Forty-one percent were men and 59% were women. Nearly 60% of patients either had DM or manifested hyperglycemia (blood glucose > 130 mg/dL): 19.5% (1627) had preexisting DM (DM+); 9.6% (801) were newly diagnosed with DM at IA: 28.6% (2391) did not have DM (DM-) but manifested hyperglycemia during hospitalization; and 36.9% (3083) remained normoglycemic. The DM status of 459 patients (5.4%) was unascertainable. For the previously diagnosed DM+ patients, antidiabetic therapy intensified more than 2-fold during IA, primarily with insulin. Postdischarge hyperglycemia management medication doubled, with increases seen in both oral hypoglycemic agents (OHAs) and insulin. Newly diagnosed DM+ patients were also treated primarily with insulin during hospitalization and reverted to OHAs PD. A minority of DM-patients received antidiabetic therapy during IA, primarily with insulin, but 4% were diagnosed DM+ in the 15-month period PD and treated primarily with OHAs. Among those normoglycemic in the hospital, 1% were diagnosed with DM and treated with OHAs PD. Conclusion: Hyperglycemia management was intensified for all DM+ patients, primarily with insulin in the hospital and both insulin and OHAs PD. A better understanding of this natural history and antidiabetic transitional care could facilitate better discharge planning and thus improve diabetes care.

AB - Background: While studies have evaluated the impact of hyperglycemia during hospitalization, little is known about its management before and after admission. Methods: We sampled a managed care outpatient database (8547 patients) with linkage to inpatient data from June 1, 2003 to June 30, 2006, evaluating hyperglycemia management preadmission (PA), during index admission (IA), and postdischarge (PD). Antihyperglycemic medications used during PA, IA, and PD for up to 15 months were available for 2898 patients from this cohort. Diabetes mellitus (DM) status was determined from ICD-9 codes. Results: Patients at IA had an average age of 60 ± 18 years. Forty-one percent were men and 59% were women. Nearly 60% of patients either had DM or manifested hyperglycemia (blood glucose > 130 mg/dL): 19.5% (1627) had preexisting DM (DM+); 9.6% (801) were newly diagnosed with DM at IA: 28.6% (2391) did not have DM (DM-) but manifested hyperglycemia during hospitalization; and 36.9% (3083) remained normoglycemic. The DM status of 459 patients (5.4%) was unascertainable. For the previously diagnosed DM+ patients, antidiabetic therapy intensified more than 2-fold during IA, primarily with insulin. Postdischarge hyperglycemia management medication doubled, with increases seen in both oral hypoglycemic agents (OHAs) and insulin. Newly diagnosed DM+ patients were also treated primarily with insulin during hospitalization and reverted to OHAs PD. A minority of DM-patients received antidiabetic therapy during IA, primarily with insulin, but 4% were diagnosed DM+ in the 15-month period PD and treated primarily with OHAs. Among those normoglycemic in the hospital, 1% were diagnosed with DM and treated with OHAs PD. Conclusion: Hyperglycemia management was intensified for all DM+ patients, primarily with insulin in the hospital and both insulin and OHAs PD. A better understanding of this natural history and antidiabetic transitional care could facilitate better discharge planning and thus improve diabetes care.

KW - Diabetes

KW - Hospital management

KW - Hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=67549118954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67549118954&partnerID=8YFLogxK

U2 - 10.3810/pgm.2009.05.2003

DO - 10.3810/pgm.2009.05.2003

M3 - Article

VL - 121

SP - 61

EP - 66

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 3

ER -